2.29

2.97% -0.07

Dogwood Therapeutics Inc (DWTX)

Overview News Price History Discussions Forecast

Dogwood Therapeutics Inc stock is traded at $2.29, with a volume of 70,165. It is down -2.97% in the last 24 hours and up +27.93% over the past month. Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.

Previous Close:

$2.36

Open:

$2.37

24h Volume:

70,165

Relative Volume:

1.10

Market Cap:

$77.84M

Revenue:

Net Income/Loss:

$-28.32M

P/E Ratio:

-0.216

EPS:

-10.6039

Net Cash Flow:

$-15.52M

1W Performance:

-13.58%

1M Performance:

+27.93%

6M Performance:

-25.89%

1Y Performance:

-54.20%

1-Day Range:

$2.2509

$2.38

1-Week Range:

$2.2509

$2.74

52-Week Range:

$1.28

$9.50

Dogwood Therapeutics Inc Stock (DWTX) Company Profile

Name

Dogwood Therapeutics Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(866) 620-8655

Address

44 MILTON AVENUE, ALPHARETTA

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

DWTX's Discussions on Twitter

Compare DWTX vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DWTX Dogwood Therapeutics Inc	2.29	79.20M	0	-28.32M	-15.52M	-10.60
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Dogwood Therapeutics Inc Stock (DWTX) Latest News

Aug 21, 2026

Dogwood (DWTX) Update: Records a 6.87% Increase to $2.49 at the Close; Boundary Watch: the Supplied Trading Band Runs From $2.37 to $2.61 in the Latest SessionImpulse Wave - vinanet.vn

Aug 21, 2026

Dogwood Therapeutics, Inc. (NASDAQ: DWTX) Stock Price, News & Analysis - Kalkine

Aug 21, 2026

Aug 20, 2026

Armistice Capital Expands Dogwood Therapeutics Stake Amid Biotec - GuruFocus

Aug 20, 2026

Aug 19, 2026

Dogwood (DWTX) Earnings Reading: Profit Per Share Clears Its Benchmark in the Current Update; Latest Reaction - vinanet.vn

Aug 19, 2026

Aug 18, 2026

Research Analysts Offer Predictions for DWTX Q3 Earnings - MarketBeat

Aug 18, 2026

Aug 17, 2026

Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026 - The Manila Times

Aug 17, 2026

Halneuron Has Been Tested on More Than 800 Patients—What’s Next? - Stock Titan

Aug 17, 2026

What is HC Wainwright's Forecast for DWTX FY2029 Earnings? - MarketBeat

Aug 17, 2026

Aug 14, 2026

Dogwood Therapeutics, Inc. 2026: Revenue ($14.06M), EPS ($0.34) — 10-Q Summary - TradingView

Aug 14, 2026

Dogwood Therapeutics (DWTX) logs $16.5M H1 loss and warns on going concern outlook - Stock Titan

Aug 14, 2026

Armistice Capital (DWTX) discloses 9.99% Dogwood Therapeutics ownership in 13G/A - Stock Titan

Aug 14, 2026

Maxim Group Maintains Dogwood Therapeutics(DWTX.US) With Buy Rating, Maintains Target Price $15 - Moomoo

Aug 14, 2026

Aug 13, 2026

Dogwood Therapeutics (NASDAQ:DWTX) Releases Earnings Results, Misses Estimates By $0.21 EPS - MarketBeat

Aug 13, 2026

Form 8K Dogwood Therapeutics Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Dogwood Therapeutics Reports $11.5 Million Second-Quarter Net Loss - Quiver Quantitative

Aug 13, 2026

Dogwood Therapeutics reports Q2 2026 net loss of $11.5M, IPR&D charge of $9.19M; $9.6M cash - TradingView

Aug 13, 2026

DWTX: Halneuron Phase 2b trial nears completion as Q2 net loss widens on higher R&D and impairment - TradingView

Aug 13, 2026

Dogwood Therapeutics Announces Second Quarter 2026 Financial Results - The Manila Times

Aug 13, 2026

Aug 11, 2026

Dogwood Therapeutics (DWTX) Rises 2.78% as Buyers Defend Key $1.76 SupportMAMA Signal - vinanet.vn

Aug 11, 2026

Aug 10, 2026